Who we are

EqVita AG is a spin-off from the University of Basel, established in May 2024 with a mission to improve the care of both children and adults living with endocrine diseases.
We believe in a future where every individual affected by endocrine disorders receives care tailored specifically to their unique needs. Driven by innovation, compassion, and collaboration, EqVita AG is committed to bridging the gap between groundbreaking research and real-world clinical application. By empowering patients and healthcare professionals alike, we strive to support healthier lives and improved outcomes for all.

Our Vision 

Advancing towards prospective, individualized monitoring & treatment optimization of endocrine diseases
To realize our vision, we are harnessing advanced data analytics and digital health solutions, enabling early detection and personalized management for endocrine conditions. Our team collaborates closely with clinicians and  researchers, ensuring that our solutions respond to genuine clinical needs while remaining accessible and user-friendly. Through continuous feedback and adaptation, we aim to set new standards in endocrinology care, transforming patient journeys from diagnosis to lifelong well-being.

Our Strategy

Developing integrated, comprehensive clinical-based predictive digital solutions and medical devices 
To address the current medical need in endocrine diseases, we are creating computerized solutions for individualized monitoring and dose optimization. These digital health solutions use AI & pharmacometric computer modelling to describe thyroid disease dynamics, drawing on a clinical datasets to account for patient and disease factors to predict individual disease activity and treatment response.

Our portfolio

Initial focus is endocrinology including:
- Thyroid diseases
- Growth hormone disorders

EqVita AG

Org chart

Teams

Offices